Continuous insulin delivery: Omnipod automated insulin delivery integrating with CGM. Razor-blade model — Pod recurring revenue per patient.
Conviction●○○○○1 of 5
Research target—Snapshot target
Thesis statusNEEDS_MORE_DATALast reviewed Not reviewed
Market cap$11.39BSnapshot value
Automated insulin delivery adoption; CGM integration driving Pod demand; Type 2 diabetes expansion; pediatric adoption.
Competitive pressure from Medtronic/Tandem; reimbursement concentration; GLP-1 reducing insulin-dependent diabetes prevalence long-term.
needs X/Reddit sentiment sweep
Snapshot · Not reviewed🟢 Confirmed · ins+$0.9M(2buy👥) · 13F 13+/12- · short↑0.29
Snapshot · Not reviewed